{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:30:34Z","timestamp":1783380634185,"version":"3.54.6"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.02888","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T07:22:26Z","timestamp":1543303346000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects"],"prefix":"10.3389","volume":"9","author":[{"given":"Shio-Shin","family":"Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Yao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1128\/AAC.00091-15","article-title":"Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia.","volume":"59","author":"Bass","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/jac\/dkh358","article-title":"In vitro activity of AVE1330A, an innovative broad-spectrum non-\u03b2-lactam \u03b2-lactamase inhibitor.","volume":"54","author":"Bonnefoy","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","article-title":"Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.","volume":"165","author":"Bratu","year":"","journal-title":"Arch. Intern. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/jac\/dki175","article-title":"Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.","volume":"56","author":"Bratu","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00567-17","article-title":"Meropenem-vaborbactam tested against contemporary Gram-negative isolates collected worldwide during 2014, including carbapenem-resistant, KPC-producing, multidrug-resistant, and extensively drug-resistant Enterobacteriaceae.","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1128\/AAC.01114-07","article-title":"Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-\u03b2-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.","volume":"52","author":"Castanheira","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jmii.2014.05.010","article-title":"Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.","volume":"48","author":"Chang","year":"2015","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1128\/AAC.00414-18","article-title":"Aztreonam-avibactam combination restores susceptibility of aztreonam in dual-carbapenemase-producing-Enterobacteriaceae.","volume":"62","author":"Chew","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1179\/joc.2009.21.6.621","article-title":"Emergence of carbapenem-resistant Escherichia coli in Taiwan: resistance due to combined CMY-2 production and porin deficiency.","volume":"21","author":"Chia","year":"2009","journal-title":"J. Chemother."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00391-17","article-title":"Roles of ramR and tet(A) mutations in conferring tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae clinical isolates.","volume":"61","author":"Chiu","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26691-z","article-title":"Carbapenem nonsusceptible Klebsiella pneumoniae in Taiwan: dissemination and increasing resistance of carbapenemase producers during 2012-2015.","volume":"8","author":"Chiu","year":"2018","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069428","article-title":"National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase.","volume":"8","author":"Chiu","year":"2013","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jmii.2015.02.400","article-title":"\u201cAn analysis of carbapenem resistant Enterobacteriaceae, associated nosocomial infections, and contact isolation measures,\u201d in","author":"Chuang","year":"2015","journal-title":"Proceedings of the Abstracts of the 7th International Congress of the Asia Pacific So"},{"key":"B14","year":"2018","journal-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-eighth Informational Supplement M100-S28"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/jac\/dkp029","article-title":"Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.","volume":"63","author":"Doumith","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3201\/eid2311.170833","article-title":"Phylogenetic analysis of Klebsiella pneumoniae from hospitalized children.","volume":"23","author":"Ejaz","year":"2017","journal-title":"Pakistan. Emerg. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1128\/AAC.01235-09","article-title":"In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and\/or colistin.","volume":"54","author":"Endimiani","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","volume":"26","year":"2018","journal-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 5.0"},{"key":"B20","volume":"16","year":"2018","journal-title":"Prescribing Information For Tygacil (Tigecycline)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/1469-0691.12325","article-title":"High rate of faecal carriage of extended-spectrum \u03b2-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco.","volume":"20","author":"Girlich","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/cid\/cir202","article-title":"Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.","volume":"53","author":"Gupta","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01968-17","article-title":"In vitro activity of the siderophore cephalosporin, cefiderocol, against carbapenem-nonsusceptible and multidrug-resistant isolates of Gram-negative bacilli collected worldwide in 2014 to 2016.","volume":"62","author":"Hackel","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ijantimicag.2017.08.005","article-title":"Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study.","volume":"50","author":"Harris","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10096-015-2550-3","article-title":"Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong.","volume":"35","author":"Ho","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jmii.2012.08.029","article-title":"Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.","volume":"47","author":"Huang","year":"2014","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jmii.2016.12.003","article-title":"First report of OXA-48 carbapenemase-producing Escherichia coli in Taiwan.","volume":"50","author":"Jao","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B29","first-page":"1068","article-title":"Metallo-\u03b2-lactamase producing Escherichia coli and Klebsiella pneumoniae: a rising threat for hospitalized children.","volume":"66","author":"Javed","year":"2016","journal-title":"J. Pak. Med. Assoc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/jac\/dkw398","article-title":"Distribution of ESBLs, AmpC \u03b2-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).","volume":"72","author":"Jean","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.2147\/IDR.S181085","article-title":"Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific Region: results from the Study for Monitoring the Antimicrobial Resistance Trends (SMART).","volume":"11","author":"Jean","year":"","journal-title":"Infect. Drug Resist."},{"key":"B32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/fmb.14.135","article-title":"Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options.","volume":"10","author":"Jean","year":"2015","journal-title":"Future Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.2147\/IDR.S175679","article-title":"In vitro activity of ceftazidime-avibactam, ceftolozane-tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).","volume":"11","author":"Jean","year":"","journal-title":"Infect. Drug Resist."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1128\/AAC.06364-11","article-title":"The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae.","volume":"56","author":"Jernigan","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/972646","article-title":"Carbapenem resistance among Enterobacter species in a tertiary care hospital in central India.","volume":"2014","author":"Khajuria","year":"2014","journal-title":"Chemother. Res. Pract."},{"key":"B36","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jmii.2016.12.008","article-title":"Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.","volume":"50","author":"Ku","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.diagmicrobio.2011.09.004","article-title":"Pelvic abscess caused by New Delhi metallo-\u03b2-lactamase-1-producing Klebsiella oxytoca in Taiwan in a patient who underwent renal transplantation in China.","volume":"71","author":"Lai","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2018.09.007","article-title":"Implementation of a national quality improvement program to enhance hand hygiene in nursing homes in Taiwan.","author":"Lai","year":"2018","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B40","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jfma.2012.09.021","article-title":"Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan.","volume":"112","author":"Lai","year":"2013","journal-title":"J. Formos. Med. Assoc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1089\/mdr.2018.0080","article-title":"Carbapenemase-producing carbapenem-resistant Enterobacteriaceae from Bangkok, Thailand, and their detection by the Carba NP and modified carbapenem inactivation method tests.","volume":"24","author":"Laolerd","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"B42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jmii.2016.12.001","article-title":"Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan.","volume":"50","author":"Lee","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jmii.2015.06.003","article-title":"Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.","volume":"50","author":"Lee","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-11-32","article-title":"Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.","volume":"11","author":"Lee","year":"2012","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1128\/JCM.02466-08","article-title":"Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection.","volume":"47","author":"Lee","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijantimicag.2011.03.020","article-title":"High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination.","volume":"38","author":"Lee","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2018.02.001","article-title":"Predominance of methicillin-resistant Staphylococcus aureus in the residents and environments of long-term care facilities in Taiwan.","author":"Liu","year":"2018","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B48","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace.","volume":"215","author":"Logan","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1590\/0037-8682-0209-2017","article-title":"Evaluation of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Rio Grande do Sul, Brazil.","volume":"50","author":"Lorenzoni","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"B50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1099\/jmm.0.050492-0","article-title":"Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009.","volume":"62","author":"Ma","year":"","journal-title":"J. Med. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-599","article-title":"Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.","volume":"13","author":"Ma","year":"","journal-title":"BMC Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jmii.2016.07.004","article-title":"Laboratory investigation of a suspected outbreak caused by Providencia stuartii with intermediate resistance to imipenem at a long-term care facility.","volume":"51","author":"Mao","year":"2018","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1128\/AAC.01103-07","article-title":"Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.","volume":"52","author":"Marchaim","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/2229-516X.198520","article-title":"Carbapenemase-producing Enterobacteriaceae: risk factors for infection and impact of resistance on outcomes.","volume":"7","author":"Mariappan","year":"2017","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186195","article-title":"Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.","volume":"12","author":"McConville","year":"2017","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4103\/ijmm.IJMM_16_386","article-title":"Identification of carbapenemase-mediated resistance among Enterobacteriaceae bloodstream isolates: a molecular study from India.","volume":"35","author":"Mohanty","year":"2017","journal-title":"Indian J. Med. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1128\/AAC.01451-07","article-title":"Genetic structures at the origin of acquisition of the \u03b2-lactamase blaKPC gene.","volume":"52","author":"Naas","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B58","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1111\/1469-0691.12091","article-title":"Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge.","volume":"19","author":"Navarro-San Francisco","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00220","article-title":"Comparative genomic analysis of a clinical isolate of Klebsiella quasipneumoniae subsp. similipneumoniae, a KPC-2 and OKP-B-6 beta-lactamases producer harboring two drug-resistance plasmids from southeast Brazil.","volume":"9","author":"Nicol\u00e1s","year":"2018","journal-title":"Front. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","article-title":"The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.","volume":"9","author":"Nordmann","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1473-3099(16)30528-X","article-title":"Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study.","volume":"17","author":"Quan","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/AAC.06268-11","article-title":"Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.","volume":"56","author":"Qureshi","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of infections caused by extended-spectrum-\u03b2-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae.","volume":"31","author":"Rodr\u00edguez-Ba\u00f1o","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ijantimicag.2018.06.015","article-title":"Integrons and insertion sequence common region 1 (ISCR1) of carbapenem-non-susceptible Gram-negative bacilli in fecal specimens from 5000 patients in southern China.","volume":"52","author":"Rui","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1099\/jmm.0.045229-0","article-title":"Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia.","volume":"61","author":"Sa\u00efdani","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/14787210.2018.1436966","article-title":"Management of infections caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: current evidence and future prospects.","volume":"16","author":"Sheu","year":"2018","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B67","volume":"6","year":"2017","journal-title":"The Centers for Disease Control and Prevention, Taiwan"},{"key":"B68","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/cid\/ciw741","article-title":"Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia.","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151897","article-title":"Clinical significance of community- and healthcare-acquired carbapenem-resistant Enterobacteriaceae isolates.","volume":"11","author":"Tang","year":"2016","journal-title":"PLoS One"},{"key":"B70","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/677157","article-title":"Rising rates of carbapenem-resistant Enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.","volume":"35","author":"Thaden","year":"2014","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jmii.2017.03.003","article-title":"The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan.","volume":"50","author":"Tseng","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B72","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/1469-0691.12697","article-title":"Treating infections caused by carbapenemase-producing Enterobacteriaceae.","volume":"20","author":"Tzouvelekis","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B74","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-Lactam\/\u03b2-Lactamase inhibitor combinations.","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121668","article-title":"Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan.","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx471","article-title":"Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).","author":"Woodford","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B78","volume":"16","year":"2017","journal-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery and Development of New Antibiotics"},{"key":"B79","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S1726-4901(10)70129-5","article-title":"First identification of a patient colonized with Klebsiella pneumoniae carrying blaNDM-1 in Taiwan.","volume":"73","author":"Wu","year":"2010","journal-title":"J. Chin. Med. Assoc."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/srep32665","article-title":"High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae.","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/jac\/dkr242","article-title":"Efficacy and safety of tigecycline: a systematic review and meta-analysis.","volume":"66","author":"Yahav","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B82","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/JCM.01263-11","article-title":"Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital.","volume":"50","author":"Yang","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2017.10.006","article-title":"Update on fosfomycin-modified genes in Enterobacteriaceae.","author":"Yang","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B84","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ebiom.2017.04.032","article-title":"Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China.","volume":"19","author":"Zhang","year":"2017","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02888\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T07:22:28Z","timestamp":1543303348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02888\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":84,"alternative-id":["10.3389\/fmicb.2018.02888"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.02888","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"article-number":"2888"}}